Related Experiment Video
Updated: May 1, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
Dermoscopic criteria associated with BRAF and NRAS mutation status in primary cutaneous melanoma
F C Pozzobon1, J A Puig-Butillé, T González-Alvarez
1Dermatology Department, Melanoma Unit, Hospital Clinic & IDIBAPS (Institut d'Investigacions Biomèdiques August Pi i Sunyer), Barcelona, Spain; National University of Colombia, Bogotá, Colombia.
Background:
The identification of BRAF mutations in melanoma led to the development and implementation of new and effective therapies. Few clinical and histological features have been associated with this mutational status.
Objectives:
The main objective of this study was to investigate clinical, histopathological and dermoscopic characteristics of primary melanomas according to BRAF or NRAS mutational status.
Methods:
An observational retrospective study including melanoma dermoscopy images assessed for somatic mutations in BRAF and NRAS.
Results:
Seventy-two patients were included, 30 women (42%) and 42 men (58%), mean age was 59 ± 15.51 years. BRAF-mutated melanomas were more frequently located on the trunk (n = 18, 64% for BRAF-mutated vs. n = 11, 29% for wild-type melanomas, P = 0.013). Histological ulceration was associated with the presence of BRAF mutations [odds ratio (OR) 3.141; 95% confidence interval (CI) 1.289-7.655; P = 0.002]. The Breslow index tended to be thicker in BRAF-mutated compared with wild-type (P = 0.086). BRAF mutations were present in 28 (39%) patients and only four cases were positive for NRAS mutations (6%), BRAF and NRAS mutations being mutually exclusive. The presence of dermoscopic peppering was associated with MAPK mutations (BRAF and NRAS) (OR 1.68; 95% CI 1.089-2.581; P = 0.015). Dermoscopic ulceration was also associated with BRAF mutations excluding acral and facial melanomas (OR 2.64; 95% CI 1.032-6.754).
Conclusions:
This study showed a correlation between BRAF and NRAS status and dermoscopic findings of 'peppering' as an expression of regression and melanophages in the dermis, suggesting a morphological consequence of immune behaviour in BRAF-mutated melanomas.
Insights
BRAF mutations in melanoma correlate with specific clinical and dermoscopic features, including trunk location and dermoscopic peppering. These findings may reflect underlying immune responses in BRAF-mutated melanomas.
Area of Science:
- Dermatology
- Oncology
- Genetics
Background:
- BRAF mutations are key drivers in melanoma, leading to targeted therapies.
- Few clinical or histological features are reliably linked to BRAF mutational status.
Purpose of the Study:
- To investigate clinical, histopathological, and dermoscopic characteristics of primary melanomas based on BRAF or NRAS mutational status.
Main Methods:
- Observational retrospective study analyzing dermoscopy images of melanoma patients.
- Somatic mutations in BRAF and NRAS were assessed.
Main Results:
- BRAF-mutated melanomas were more common on the trunk (64%) and showed histological ulceration (OR 3.141, P=0.002).
- Dermoscopic peppering was associated with MAPK mutations (BRAF/NRAS) (OR 1.68, P=0.015).
- BRAF and NRAS mutations were mutually exclusive (39% BRAF, 6% NRAS).
Conclusions:
- BRAF/NRAS status correlates with dermoscopic 'peppering,' indicating regression and dermal melanophages.
- This suggests a potential morphological consequence of immune behavior in BRAF-mutated melanomas.
More Related Videos
08:18Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma
Published on: September 8, 2021
11:02The Three-Dimensional Human Skin Reconstruct Model: a Tool to Study Normal Skin and Melanoma Progression
Published on: August 3, 2011
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
The Ras Gene
Ras is a...
Abnormal Proliferation
MAPK Signaling Cascades
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...